COMMUNIQUÉS West-GlobeNewswire

New ReNu® Data from Organogenesis Highlighted at ICRS 2019 World Congress

05/10/2019 - 15:00

CANTON, Mass. and VANCOUVER, British Columbia, Oct. 05, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and [...]

Pure Sunfarms, la coentreprise d'Emerald Health Therapeutics, commence à expédier ses produits de marque à base de cannabis à un grossiste de la province de la Colombie-Britannique

05/10/2019 - 00:38

VANCOUVER, Colombie-Britannique, 04 oct. 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF), a annoncé aujourd'hui que sa coentreprise détenue à 50 % pour la production [...]

Lexington Biosciences Converts Amounts Owed to Unsecured Demand Loans

04/10/2019 - 21:28

VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) announces that it has reached agreement with third parties as well as certain [...]

HEXO Corp annonce la démission de son chef de la direction financière

04/10/2019 - 22:05

GATINEAU, Québec, 04 oct. 2019 (GLOBE NEWSWIRE) -- HEXO Corp, (« HEXO » ou la « Société ») (TSX : HEXO ; NYSE : HEXO) a annoncé aujourd'hui que le chef de la direction financière de la Société, Michael Monahan, a pris [...]

HEXO Corp Announces Resignation of Chief Financial Officer

04/10/2019 - 22:05

GATINEAU, Quebec, Oct. 04, 2019 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO; NYSE:HEXO) today announced that the company’s Chief Financial Officer, Michael Monahan, has made the decision to resign [...]

Avadel Announces Resignation of Kevin Kotler from Board of Directors

04/10/2019 - 22:05

DUBLIN, Ireland, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, a once-nightly formulation of sodium oxybate, for narcolepsy, today announced that [...]

Natus Medical to Hold 2019 Third Quarter Financial Results Conference all on October 24th

04/10/2019 - 22:15

PLEASANTON, Calif., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of [...]

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/10/2019 - 22:30

BURLINGTON, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to 13 new employees consisting of an aggregate of 80,550 stock options and 13,425 [...]

Aeterna Zentaris Announces Appointment of New President and Chief Executive Officer

04/10/2019 - 22:59

CHARLESTON, S.C., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today announced the appointment of Klaus Paulini as President and Chief Executive Officer of the Company, effective [...]

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/10/2019 - 23:30

CRESTWOOD, Ky. and WALTHAM Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2019

04/10/2019 - 18:00

Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- [...]

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 30 Septembre 2019

04/10/2019 - 18:00

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers LYON, France, 04 oct. 2019 (GLOBE NEWSWIRE) -- Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : FR0011471135 – [...]

Octroi de 1,7 million de dollars en vue du développement de la plateforme ciblée en oncologie de Theratechnologies

04/10/2019 - 19:00

MONTREAL, 04 oct. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que la Société Canadienne du cancer (SCC) et le gouvernement du Québec, par le biais du Consortium [...]

1.7 Million Dollars Grant Towards Development of Theratechnologies’ Targeted Oncology

04/10/2019 - 19:00

MONTREAL, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the Canadian Cancer Society and the Government of Quebec, through the Consortium Québécois sur [...]

Dabir Surfaces Inc. Announces Launch of the Dabir Patient Care System

04/10/2019 - 19:25

CHICAGO, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Dabir Surfaces, Inc., a subsidiary of Methode Electronics, Inc. (NYSE: MEI), focused on improving patient outcomes through the design and manufacture of an innovative solution [...]

United Health Products Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the HemoStyp® Device for Use in Surgical Procedures

04/10/2019 - 13:00

HENDERSON, Nev., Oct. 04, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC: UEEC) today announced that it has submitted a Premarket Approval (PMA) application for Class III approval to the FDA for [...]

Emerald Health Therapeutics’ Joint Venture Pure Sunfarms Begins Shipping Branded Cannabis Product to British Columbia Provincial Wholesaler

04/10/2019 - 13:02

VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced its 50%-owned joint venture for large-scale, low-cost, high-quality [...]

Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting

04/10/2019 - 13:30

Faster Progressing Patients Who Received Reldesemtiv in the Trial Demonstrated Statistically Significant Differences in the Decline in ALSFRS-R Total Score SOUTH SAN FRANCISCO, Calif., Oct. 04, 2019 (GLOBE NEWSWIRE) -- [...]

Optinose Appoints Michael Richardson to New Position of Vice President, Business Development

04/10/2019 - 14:00

YARDLEY, Pa., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported the creation of a new [...]